The global automated liquid handling technologies market is witnessing rapid growth, driven by increasing automation in life sciences, pharmaceuticals, and diagnostic laboratories. With a projected rise from USD 2.9 billion in 2025 to USD 6.3 billion by 2032, the market is set to expand at a CAGR of 11.55% during the forecast period. The growing need for precision, efficiency, and safety in liquid handling is shaping the future of laboratory workflows worldwide.
Market Insights
Automated liquid handling (ALH) systems are revolutionizing laboratories by reducing manual errors, increasing throughput, and ensuring consistency. These systems are especially crucial in applications requiring precise and small-volume sample handling. The shift from traditional methods to automated platforms is transforming research and diagnostics, enhancing reproducibility and reducing human dependency.
The COVID-19 pandemic accelerated this transformation, highlighting the importance of efficient and contamination-free sample processing. Automated systems emerged as vital tools in managing large-scale testing requirements with limited human intervention.
Market Drivers
Several key factors are driving the adoption of automated liquid handling technologies:
• Technological Innovations: Integration of artificial intelligence and machine learning into ALH systems enables real-time error correction and adaptive handling. This results in higher accuracy and fewer workflow interruptions.
• Cost and Resource Efficiency: Automation minimizes labor costs and optimizes reagent usage through miniaturized assay platforms, making experiments more cost-effective.
• R&D and Genomics Expansion: The increasing complexity of genomic and drug discovery studies is boosting demand for advanced automation tools. Automated platforms streamline complex workflows, from DNA extraction to qPCR setup.
• Increased Outsourcing: Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) are increasingly integrating automation to meet regulatory demands and improve scalability.
Business Opportunity
The market presents strong opportunities in emerging economies where life sciences infrastructure is growing. The surge in biotech start-ups, along with government funding for research, is creating fertile ground for the adoption of ALH technologies.
Companies are launching innovative products tailored to specific needs. For example, DISPENDIX introduced the I.DOT DW in 2021, a device capable of detecting empty source wells and validating dispensing volumes, enhancing reliability in critical research applications.
Pharma and biotech firms, driven by competitive pressures to accelerate drug development, are heavily investing in flexible and scalable automation systems. In turn, vendors are offering modular and compact devices that can be easily integrated into existing lab environments.
Regional Analysis
North America leads the market due to its strong presence of key manufacturers, established healthcare infrastructure, and early adoption of advanced laboratory technologies. The U.S., in particular, is experiencing a growing push toward lab automation due to a shortage of skilled lab personnel and rising clinical testing demand.
Investments in clinical lab equipment have been steadily increasing, and the shortfall in trained laboratory scientists is further compelling labs to automate to maintain efficiency and throughput.
Asia Pacific is expected to register substantial growth, supported by rising foreign direct investments and government initiatives to strengthen biotechnology research. Countries like India and China are expanding hospital and diagnostic infrastructures, driving demand for lab automation solutions.
In India, the hospitals and diagnostic centers sector witnessed a 39% increase in FDI during 2021–2022, which is expected to contribute significantly to the growth of automated liquid handling technologies in the region.
Key Players
Leading players in the automated liquid handling technologies market are focusing on innovation, partnerships, and geographic expansion to strengthen their market position. They are introducing next-generation systems designed for enhanced flexibility, reduced lab footprint, and integration capabilities.
Major companies include:
• Thermo Fisher Scientific, Inc.
• Agilent Technologies
• PerkinElmer, Inc.
• Hamilton Company
• Eppendorf AG
• QIAGEN
• Tecan Trading AG
• Labcyte Inc.
• Gilson, Inc.
• BioTek Instruments, Inc.
• Formulatrix, Inc.
• METTLER TOLEDO
• Corning Incorporated
• Aurora Biomed, Inc.
• Analytik Jena AG
• Hudson Robotics
• Danaher
• AUTOGEN, INC.
• Lonza
In February 2022, SPT Labtech launched the apricot DC1, a compact 4-in-1 platform to automate routine pipetting processes, boosting lab productivity. QIAGEN followed in March 2021 with the launch of QIAcube Connect MDx for automated sample processing in diagnostic labs worldwide.
Segmentation
By Product
• Automated Liquid Handling Workstations
o Standalone Workstations
o Integrated Workstations
o Multipurpose Workstations
o Pipetting Workstations
o Specialized Liquid Handlers
o Workstation Modules
• Reagents & Consumables
o Reagents
o Accessories
By Application
• Drug Discovery & ADME-Tox Research
• Cancer & Genomic Research
• Bioprocessing/Biotechnology
• Others
By End-User
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Please note: Delivery Timelines - 5 working days.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook